{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:24:13Z","timestamp":1782199453702,"version":"3.54.5"},"reference-count":38,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej14-0456","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T22:02:28Z","timestamp":1422482548000},"page":"329-337","source":"Crossref","is-referenced-by-count":27,"title":["Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area"],"prefix":"10.1507","volume":"62","author":[{"given":"Yukari","family":"Fujita","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kozawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Iwahashi","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syo","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Okita","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Imagawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. <i>N Engl J Med<\/i> 314: 1360-1368.","DOI":"10.1056\/NEJM198605223142106"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. <i>Diabete<\/i>s 14: 619-633.","DOI":"10.2337\/diab.14.10.619"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Keenan HA, Sun JK, Levine J, Doria A, Aiello LP, et al. (2010) Residual insulin production and pancreatic &beta;-cell turnover after 50 years of diabetes: Joslin Medalist Study. <i>Diabetes<\/i> 59: 2846-2853.","DOI":"10.2337\/db10-0676"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. <i>Diabetes Care<\/i> 37: S81-90.","DOI":"10.2337\/dc14-S081"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kobayashi T, Nakanishi K, Nakase H, Kajio H, Okubo M, et al. (1997) In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. <i>Diabetes<\/i> 46: 1567-1571.","DOI":"10.2337\/diacare.46.10.1567"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Otabe S, Yasuda K, Mori Y, Shimokawa K, Kadowaki H, et al. (1999) Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion. <i>Biochem Biophys Res Commun<\/i> 259: 149-156.","DOI":"10.1006\/bbrc.1999.0650"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Karasik A, O\u2019Hara C, Srikanta S, Swift M, Soeldner JS, et al. (1989) Genetically programmed selective islet &beta;-cell loss in diabetic subjects with Wolfram\u2019s syndrome. <i>Diabetes Care<\/i> 12: 135-138.","DOI":"10.2337\/diacare.12.2.135"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tran TC, van Lanschot JJ, Bruno MJ, van Eijck CH (2009) Functional changes after pancreatoduodenectomy: diagnosis and treatment. <i>Pancreatology<\/i> 9: 729-737.","DOI":"10.1159\/000264638"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic &beta;-cell mass in European subjects with type 2 diabetes. <i>Diabetes Obes Metab<\/i> 10 Suppl 4: 32-42.","DOI":"10.1111\/j.1463-1326.2008.00969.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, et al. (2002) Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. <i>Diabetologia<\/i> 45: 85-96.","DOI":"10.1007\/s125-002-8248-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, et al. (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. <i>J Clin Endocrinol Metab<\/i> 88: 2300-2308.","DOI":"10.1210\/jc.2002-020735"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. <i>Diabetes<\/i> 52: 102-110.","DOI":"10.2337\/diabetes.52.1.102"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yoneda S, Uno S, Iwahashi H, Fujita Y, Yoshikawa A, et al. (2013) Predominance of &beta;-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes. <i>J Clin Endocrinol Metab<\/i> 98: 2053-2061.","DOI":"10.1210\/jc.2012-3832"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Meier JJ, Breuer TG, Bonadonna RC, Tannapfel A, Uhl W, et al. (2012) Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. <i>Diabetologia<\/i> 55: 1346-1354.","DOI":"10.1007\/s00125-012-2466-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mizukami H, Takahashi K, Inaba W, Tsuboi K, Osonoi S, et al. (2014) Involvement of oxidative stress-induced DNA damage, endoplasmic reticulum stress, and autophagy deficits in the decline of &beta;-cell mass in Japanese type 2 diabetic patients. <i>Diabetes Care <\/i>37: 1966-1974.","DOI":"10.2337\/dc13-2018"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic &beta; cell dedifferentiation as a mechanism of diabetic &beta; cell failure. <i>Cell<\/i> 150: 1223-1234.","DOI":"10.1016\/j.cell.2012.07.029"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Waguri M, Yamamoto K, Miyagawa JI, Tochino Y, Yamamori K, et al. (1997) Demonstration of two different processes of &beta;-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan. <i>Diabetes<\/i> 46: 1281-1290.","DOI":"10.2337\/diab.46.8.1281"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamamoto K, Miyagawa J, Waguri M, Sasada R, Igarashi K, et al. (2000) Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. <i>Diabetes<\/i> 49: 2021-2027.","DOI":"10.2337\/diabetes.49.12.2021"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. <i>Diabetologia<\/i> 28: 412-419.","DOI":"10.1007\/BF00280883"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kosaka K, Hagura R, Kuzuya T (1977) Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. <i>Diabetes<\/i> 26: 944-952.","DOI":"10.2337\/diab.26.10.944"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. <i>Diabetologia<\/i> 44: 929-945.","DOI":"10.1007\/s001250100580"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Faber OK, Binder C (1977) C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. <i>Diabetes<\/i> 26: 605-610.","DOI":"10.2337\/diab.26.7.605"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, et al. (1981) Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. <i>Acta Med Scand<\/i> 210: 153-156.","DOI":"10.1111\/j.0954-6820.1981.tb09793.x"},{"key":"24","unstructured":"24. Scheen AJ, Castillo MJ, Lef&egrave;bvre PJ (1996) Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. <i>Diabetes Metab<\/i> 22: 397-406."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Meier JJ, Menge BA, Breuer TG, M&uuml;ller CA, Tannapfel A, et al. (2009) Functional assessment of pancreatic beta-cell area in humans. <i>Diabetes<\/i> 58: 1595-1603.","DOI":"10.2337\/db08-1611"},{"key":"26","unstructured":"26. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO_IDF Consultation. World Health Org. http:\/\/www.who.int\/diabetes\/publications\/diagnosis_diabetes2006\/en\/"},{"key":"27","unstructured":"27. Asano T, Kawamura M, Watanabe T, Abe M, Chin R, et al. (2008) Indices of urinary and serum C-peptide corrected with fasting plasma glucose for decision-making insulin therapy in type 2 diabetes-validation and comparison. <i>J Japan Diab Soc<\/i> 51: 759-763 (In Japanese)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. <i>Diabetes Care<\/i> 22: 1462-1470.","DOI":"10.2337\/diacare.22.9.1462"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. DeFronzo RA, Matsuda M (2010) Reduced time points to calculate the composite index. <i>Diabetes Care<\/i> 33: e93.","DOI":"10.2337\/dc10-0646"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, et al. (2012) International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. <i>J Diabetes Investig<\/i> 3: 39-40.","DOI":"10.1111\/j.2040-1124.2012.00207.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sayama K, Imagawa A, Okita K, Uno S, Moriwaki M, et al. (2005) Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment. <i>Diabetologia<\/i> 48: 1560-1564.","DOI":"10.1007\/s00125-005-1829-9"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Samols E, Marri G, Marks V (1965) Promotion of insulin secretion by glucagon. <i>Lancet<\/i> 2: 415-416.","DOI":"10.1016\/S0140-6736(65)90761-0"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Shen J, Chen Z, Chen C, Zhu X, Han Y (2013) Impact of incretin on early-phase insulin secretion and glucose excursion. <i>Endocrine<\/i> 44: 403-410.","DOI":"10.1007\/s12020-012-9867-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. <i>Diabetes<\/i> 52: 581-587.","DOI":"10.2337\/diabetes.52.3.581"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pannala R, Basu A, Petersen GM, Chari ST (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. <i>Lancet Oncol<\/i> 10: 88-95.","DOI":"10.1016\/S1470-2045(08)70337-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Figler RA, Wang G, Srinivasan S, Jung DY, Zhang Z, et al. (2011) Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans.<i> Diabetes<\/i> 60: 669-679.","DOI":"10.2337\/db10-1070"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. <i>Diabetes Care<\/i> 29: 717-718.","DOI":"10.2337\/diacare.29.03.06.dc05-1538"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Gemici C, Sargin M, Uygur-Bayramicli O, Mayadagli A, Yaprak G, et al. (2013) Risk of endocrine pancreatic insufficiency in patients receiving adjuvant chemoradiation for resected gastric cancer. <i>Radiother Oncol<\/i> 107: 195-199.","DOI":"10.1016\/j.radonc.2013.04.013"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T04:31:51Z","timestamp":1498192311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/4\/62_EJ14-0456\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0456","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}